SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H.-P. Hartung, F. Munschauer, H. Schellekens, Significance of neutralizing antibodies to interferon beta during treatment of multiple sclerosis: expert opinions based on the Proceedings of an International Consensus Conference, European Journal of Neurology, 2005, 12, 8
  2. 2
    Huub Schellekens, Immunogenicity of therapeutic proteins: Clinical implications and future prospects, Clinical Therapeutics, 2002, 24, 11, 1720

    CrossRef

  3. 3
    Carolina Scagnolari, Francesca Bellomi, Ombretta Turriziani, Francesca Bagnato, Valentina Tomassini, Vito Lavolpe, Marilena Ruggieri, Fabrizio Bruschi, Giuseppe Meucci, Giordano Dicuonzo, Guido Antonelli, Neutralizing and Binding Antibodies to IFN-β: Relative Frequency in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different IFN-βPreparations, Journal of Interferon & Cytokine Research, 2002, 22, 2, 207

    CrossRef

  4. 4
    Seth Porter, Human immune response to recombinant human proteins, Journal of Pharmaceutical Sciences, 2001, 90, 1
  5. 5
    G.C. Viscomi, G. Antonelli, C. Bruno, L. Scapol, F. Malavasi, A. Funaro, E. Simeoni, S. Pestka, F. De Pisa, F. Dianzani, Antigenic Characterization of Recombinant, Lymphoblastoid, and Leukocyte IFN-alpha by Monoclonal Antibodies, Journal of Interferon <html_ent glyph="@amp;" ascii="&amp;"/> Cytokine Research, 1999, 19, 4, 319

    CrossRef

  6. 6
    Melisa A. Takacs, Sheila J. Jacobs, Ronald M. Bordens, Steven J. Swanson, Detection and Characterization of Antibodies to PEG-IFN-alpha2b Using Surface Plasmon Resonance, Journal of Interferon & Cytokine Research, 1999, 19, 7, 781

    CrossRef

  7. 7
    Mandana Khalili, Robert P. Perrillo, INTERFERON THERAPY OF HEPATITIS B, Clinics in Liver Disease, 1999, 3, 2, 363

    CrossRef

  8. 8
    G. ANTONELLI, F. BAGNATO, C. POZZILLI, E. SIMEONI, S. BASTIANELLI, M. CURRENTI, F. DE PISA, C. FIESCHI, C. GASPERINI, M. SALVETTI, F. DIANZANI, Development of Neutralizing Antibodies in Patients with Relapsing-Remitting Multiple Sclerosis Treated with IFN-β1a, Journal of Interferon & Cytokine Research, 1998, 18, 5, 345

    CrossRef

  9. 9
    Vincent Leroy, Marilyne Baud, Caroline de Traversay, Marianne Maynard-Muet, Pierre Lebon, Jean-Pierre Zarski, Role of anti-interferon antibodies in breakthrough occurrence during alpha 2a and 2b therapy in patients with chronic hepatitis C, Journal of Hepatology, 1998, 28, 3, 375

    CrossRef

  10. 10
    RACHEL M. McKENNA, KJELL E. OBERG, Antibodies to Interferon-α in Treated Cancer Patients: Incidence and Significance, Journal of Interferon & Cytokine Research, 1997, 17, 3, 141

    CrossRef

  11. 11
    L.M. THURMOND, M.J. REESE, Differential Neutralizing Activity of Human Antibodies in Interferon Antiviral and Natural Killer Cell Bioassays, Journal of Interferon & Cytokine Research, 1997, 17, 10, 619

    CrossRef

  12. 12
    G. Antonelli, E. Simeoni, M. Currenti, F. Pisa, V. Colizzi, M. Pistello, F. Dianzani, Interferon antibodies in patients with infectious diseases, Biotherapy, 1997, 10, 1, 7

    CrossRef

  13. 13
    Giuseppe C. Viscomi, Structure-activity of type I interferons, Biotherapy, 1997, 10, 1, 59

    CrossRef

  14. 14
    Maureen M. Jonas, Interferon-α for Viral Hepatitis, Journal of Pediatric Gastroenterology &amp Nutrition, 1996, 23, 2, 93

    CrossRef

  15. 15
    Ayalew Tefferi, Darryl C. Grendahl, Natural leukocyte interferon-α therapy in patients with chronic granulocytic leukemia who have antibody-mediated resistance to treatment with recombinant interferon-α, American Journal of Hematology, 1996, 52, 3
  16. 16
    Mariano Malaguarnera, Salvatore Restuccia, Giuseppe Receputo, Ignazio Giugno, Giovanni Pistone, Barbara A. Trovato, The efficacy of interferon alfa in chronic hepatitis B: a review and meta-analysis, Current Therapeutic Research, 1996, 57, 9, 646

    CrossRef

  17. 17
    Luigi Roffi, Guido Colloredo Mels, Guido Antonelli, Giorgio Bellati, Fabio Panizzuti, Alberto Piperno, Massimo Pozzi, Davide Ravizza, Giovanni Angeli, Ferdinando Dianzani, Giuseppe Mancia, Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: Prevalence, etiology, and management, Hepatology, 1995, 21, 3
  18. 18
    G. C. Viscomi, M. Grimaldi, E. Palazzini, S. Silvestri, Human leukocyte interferon alpha: Structure, pharmacology, and therapeutic applications, Medicinal Research Reviews, 1995, 15, 5
  19. 19
    Masahide Yoshikawa, Hiroshi Fukui, Tadasu Tsujii, Immunological Adverse Effects of Interferon Treatment, Clinical Immunotherapeutics, 1995, 4, 5, 361

    CrossRef

  20. 20
    Norah Terrault, S. Victor Feinman, Interferons for viral hepatitis, Transfusion Medicine Reviews, 1995, 9, 1, 29

    CrossRef

  21. 21
    G. M. DUSHEIKO, Management of chronic hepatitis C, Haemophilia, 1995, 1, S4
  22. 22
    Stephen Wong, Tony Gauthier, Kelly D. E. Kaita, Gerald Y. Minuk, The differential effects of three forms of interferon alfa on hepatic regeneration after partial hepatectomy in the rat, Hepatology, 1995, 22, 3
  23. 23
    Yun-Fan Liaw, Shi-Ming Lin, Tong-Jong Chen, Rong-Nan Chien, I-Shyan Sheen, Chia-Ming Chu, Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial, Journal of Hepatology, 1994, 20, 2, 175

    CrossRef

  24. You have free access to this content24
    G. GIANNELLI, G. ANTONELLI, G. FERA, S. VECCHIO, E. RIVA, C. BROCCIA, O. SCHIRALDI, F. DIANZANI, Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN–α) during therapy for chronic hepatitis C, Clinical & Experimental Immunology, 1994, 97, 1
  25. 25
    N. B. Finter, Cytokines in the treatment of virus infections, Biotherapy, 1994, 7, 3-4, 151

    CrossRef

  26. 26
    Guido Antonelli, Development of neutralizing and binding antibodies to interferon (IFN) in patients undergoing IFN therapy, Antiviral Research, 1994, 24, 2-3, 235

    CrossRef

  27. 27
    Gary L. Davis, Interferon treatment of chronic hepatitis C, The American Journal of Medicine, 1994, 96, 1, S41

    CrossRef

  28. 28
    David K.H. Wong, Jenny Heathcote, The role of interferon in the treatment of viral hepatitis, Pharmacology & Therapeutics, 1994, 63, 2, 177

    CrossRef

  29. 29
    A. S. F. Lok, Treatment of chronic hepatitis B, Journal of Viral Hepatitis, 1994, 1, 2
  30. 30
    Orencio Bosch, Luis Tapia, Juan Antonio Quiroga, Vicente Carreño, An escalating dose regime of recombinant interferon-alpha 2A in the treatment of chronic hepatitis C, Journal of Hepatology, 1993, 17, 2, 146

    CrossRef

  31. 31
    Robert P. Perrillo, Antiviral therapy of chronic hepatitis B: past, present, and future, Journal of Hepatology, 1993, 17, S56

    CrossRef

  32. 32
    Robert P. Perrillo, Interferon in the management of chronic hepatitis B, Digestive Diseases and Sciences, 1993, 38, 4, 577

    CrossRef

  33. 33
    Michele Milella, Guido Antoneill, Teresa Santantonio, Maurizio Currenti, Laura Monno, Nicola Mariano, Gioacchino Angarano, Ferdinando Dianzanl, Giuseppe Pastors, Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection, Liver, 1993, 13, 3
  34. 34
    Harry L.A. Janssen, Solko W. Schalm, Lucas Berk, de Man Robert A., Rudolf A. Heijtink, Repeated courses of α-interferon for treatment of chronic hepatitis type B, Journal of Hepatology, 1993, 17, S47

    CrossRef

  35. 35
    ANNA S. F. LOK, Alpha-interferon therapy for chronic hepatitis B virus infection in children and Oriental patients, Journal of Gastroenterology and Hepatology, 1991, 6, S1
  36. 36
    Gordon Baskin, Elsewhere reviews. Interferon signalling through arachidonic acid-dependent pathways: A clue to adjuvant therapy for chronic viral hepatitis?, Hepatology, 1991, 14, 2
  37. 37
    Robert P. Perrillo, Factors influencing response to interferon in chronic hepatitis B: Implications for Asian and western populations, Hepatology, 1990, 12, 6